期刊文献+

老年周围动脉闭塞性疾病患者血栓前状态的初步研究 被引量:9

Investigation on prethrombotic state of peripheral article occlusive disease in the elderly
下载PDF
导出
摘要 目的 探讨老年周围动脉闭塞性疾病 (PAOD)患者是否存在血栓前状态 (PTS)及其临床意义。方法 检测 33例确诊为老年 PAOD患者的血浆血小板α颗粒膜蛋白 - 1 4 0 (GMP- 1 4 0 )、血管性假血友病因子 (v WF)、纤维蛋白原 (FIB)、纤溶酶原 (PLG)和 D-二聚体 (DD)以及凝血酶 -抗凝血酶 复合物 (TAT)水平 ,并分别与 40例健康老人及 30例具有心血管危险因素的非 PAOD患者进行比较。结果 老年 PAOD组的 GMP- 1 4 0(1 4 .0 6± 2 .1 8μg/ L )、DD(2 .92± 1 .3μg/ L)、v WF(1 0 4 .42 %± 31 .4%)及 FIB(60 6.8± 1 1 7.8mg/ dl)水平显著高于健康对照组 (依次为 8.2 3± 1 .86μg/ L、0 .35± 0 .1 8μg/ L、53.67%± 1 1 .33%及 2 4 2 .3± 41 .7mg/ dl) (P<0 .0 0 0 1 )和心血管危险因素组 (依次为 1 1 .97± 1 .96μg/ L、1 .0 6± 0 .53μg/L、75.8%± 4.59%及 41 3.4± 67.78mg/ dl) (P<0 .0 0 1 ) ,而 PLG活性、TAT水平各组间无显著差异。结论 老年 PAOD患者存在血栓前状态 ,且与内皮功能失调密切相关 ;积极使用抗血小板制剂和抗凝剂 ,改善血管内皮功能是 PAOD治疗的核心之一。 Objective To detect whether the prethrombotic state (PTS) existed in the old patients of peripheral arterial occlusive disease (PAOD). Methods Six factors reflecting PTS including platelet a-granular membrane protein-140 (GMP-140), von willebrand factor (VWF), fibrinogen (FIB), plasminogen (PLG), d-dimer (DD) and the complex of thrombin-antithrombin Ⅲ(TAT) were tested in PAOD patients and compared with those of the old healthy controls and non-PAOD patients with cardiac risk factors. Results The levels of GMP-140 (14.06±2.18 ug /L ), DD (2.92±1.3 ug/L), vWF(104.42%±31.4%) and FIB (606.8±117.8 mg/dl) were higher in PAOD patients than those in healthy control group (8.23±1.86 μg/L, 0.35±0.18 μg/L, 53.67%±11.33% and 242.3±41.7 mg/dl, respectively) ( P <0.000 1) and cardiac risk factors group (11.97±1.96 μg/L, 1.06±0.53 μg/L, 75.8%±4.59% and 413.4±67.78 mg/dl, respectively, P <0.001). But the activity of PLG and the level of TAT in different groups have no significant difference. Conclusions PTS existed in old PAOD patients, and it had close relationship with endothelial dysfunction. More attention should be paid to the use of anti-platelet or anticoagulative agents and amelioration of vascular endothelial function in the treatment of PAOD.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2004年第1期10-11,共2页 Chinese Journal of Gerontology
基金 国家卫生部保健科研基金资助 (2 0 0 1 - 5- 0 0 6)
关键词 老年人 周围动脉闭塞性疾病 血栓前状态 动脉硬化 临床意义 血管内皮功能 抗血小板制剂 抗凝剂 Atherosclerosis (AS) Peripheral arterial occlusive disease Prethromboticstate
  • 相关文献

参考文献6

  • 1[1]Drexel H,Steurer J,Muntwyler J,et al.Predictors of the presence and extent of peripheral arterial occlusive disease [J].Circulation,1996;94(9 Suppl):Ⅱ 199-205.
  • 2[2]Blann AD,Seigneur M,Steiner M,et al.Circulating endothelial cell markers in peripheral vascular disease:Relationship to the location and extent of atherosclerotic disease [J].Eur J Clinic Invest,1997;27:916-921.
  • 3[3]Folsom AR,Wu K,Davis CE.Association of haemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis [J].Arterioscler Throm,1993;13:1829-1836.
  • 4[4]Cortellaro M,Boschetti C,Cofrancesco E,et al.The PLAT study:A multi-disciplinary study of haemostatic function and conventional risk factors vascular disease patients [J].Atherosclerosis,1991;90:109-118.
  • 5[5]Lassila R,Peltonen S,Lepantalo M,et al.Severity of peripheralatherosclerosis is associated with fibrinogen and degradation of cross-linked fibrin [J].Arterioscler Throm,1993;13:1738-1742.
  • 6[6]Lee AJ,Fowkes FGR,Lowe GDO,et al.Fibrin d-dimer,haemo-static factors and peripheral arterial disease[J].Throm Haem,1995;828-832.

同被引文献88

  • 1王存邦,欧英贤,白海,魏亚明,欧建锋,慕海霞,王晓静.应用重组人粒细胞集落刺激因子对不同人群骨髓CD34^+细胞和T细胞亚群影响的动态观察[J].中国综合临床,2004,20(9):791-793. 被引量:2
  • 2孙桂芝,赵亚鹏,周同,王鸿利,陈楠.P-选择素与血栓性疾病[J].微循环技术杂志(临床与实验),2004,8(5):322-325. 被引量:19
  • 3熊立凡,王鸿利.D-二聚体与静脉血栓症诊断——循证实验诊断学举例[J].诊断学理论与实践,2005,4(1):75-79. 被引量:35
  • 4Rost NS,Wolf PA,Kase CS,et al. Plasma concent ration of C-reactive protein and risk of ischemic Stroke and transient ischemic attack: the Framingham study[J]. Stroke, 2001,32: 2575-2579.
  • 5Muri KW,Weri CJ, Alwann W, et al. C-reactive protein and out come after ischemic Stroke [J]. Strok, 1999,30 (5) :981-985.
  • 6Sato W,TakahaShi H,Shibate A. Fibrinogen/fibrin degradation products and D-Dimer in elinical practice of discrepant results[J]. Am J Hematol, 1995,48:168-174.
  • 7Biedunkiewicz B, Lizakowski S. Blood coagulation unaffected by ozonated autohemotherapy in patients on maintenance hemodialysis [J]. Arch Med Res, 2006, 37 (8) : 1034-1037.
  • 8Lee AJ, Fowkes FGR, Lowe GDO, et al. Fibrin d-dimer. haemo static factors and peripheral arterial disease [J]. Throm Haem,1995,828-832.
  • 9Alonso-Martinez JL, Llorente-Diez B, Echegaray-Agara M,et al. C-reactive protein as a predictor of improvement and readmission in heart failure[J]. Eur J Heart Fail, 2002,4(9) :331-336.
  • 10Mullenix PS,Steele SR, Martin M J, et al. C-reactive protein level and traditional vascular risk factors in the prediction of carotid stenosis[J]. Arch Surg, 2007,142 ( 11 ) : 1066-1071.

引证文献9

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部